Therapeutic Challenges and Advances in the Management of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s219024
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Informa UK Limited